Abstract
Contrast-enhanced CT employs a standard uniphasic single-injection method (SIM), wherein administration is based on two parameters: the iodine administration rate (mgI/s) and the injection duration (s). However, as the SIM uses a fixed iodine administration rate, only a uniform contrast enhancement can be achieved with this method. The iodine administration rate can be increased only by increasing the iodine dose or shortening the injection duration, and no arbitrary adjustments can be made to the peak enhancement characteristics of the time-enhancement curves (TECs) at the fixed injection parameters used in the SIM. To address this problem, we developed a variable injection method (VIM) with a new parameter, the variation factor (VF), to adjust the TECs. A phantom study with the VIM indicated that arbitrary adjustments to the iodine administration rate could be made without changing the injection duration or increasing the iodine load. In our study, VFs of 0.3 and 0.5, which showed earlier achievement of peak enhancements, showed better temporal separation between arterial vasculature and parenchyma or the venous vasculature than that obtained with the SIM. The higher peak enhancement provided by the VF of 0.3 was also considered to improve the contrast in qualitative diagnostic examinations. A VF of 0.5 increased the duration of the enhancement and was considered to produce stable enhancement of contrast in vascular investigations. The VF is now an essential parameter, and the VIM is useful as a reasonable contrast method that may contribute to both improved visualization and improvement in the accuracy of morphologic diagnosis.
Similar content being viewed by others
References
Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. Radiology. 1998;207(3):647–55.
Bae KT, Heiken JP, Brink JA. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate—pharmacokinetic analysis and experimental porcine model. Radiology. 1998;206(2):455–64.
Fleischmann D, Hittmair K. Mathematical analysis of arterial enhancement and optimization of bolus geometry for CT angiography using the discrete Fourier transform. J Comput Assist Tomogr. 1999;23(3):474–84.
Fleischmann D, Rubin GD, Bankier AA, Hittmair K. Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography. Radiology. 2000;214(2):363–71.
Awai K, Hatcho A, Nakayama Y, Kusunoki S, Liu D, Hatemura M, et al. Simulation of aortic peak enhancement on MDCT using a contrast material flow phantom: feasibility study. Am J Roentgenol. 2006;186(2):379–85.
Awai K, Hiraishi K, Hori S. Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology. 2004;230(1):142–50.
Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV. Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology. 1995;195(2):353–7.
Yamashita Y, Komohara Y, Takahashi M, Uchida M, Hayabuchi N, Shimizu T, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material—a prospective randomized study. Radiology. 2000;216(3):718–23.
Bae KT, Seek BA, Hildebolt CF, Tao C, Zhu F, Kanematsu M, et al. Contrast enhancement in cardiovascular MDCT; effect of body weight, height, body surface area, body mass index, and obesity. Am J Roentgenol. 2008;190(3):777–84.
Kondo H, Kanematsu M, Goshima S, Tomita Y, Miyoshi T, Hatcho A, et al. Abdominal multidetector CT in patients with varying body fat percentages: estimation of optimal contrast material dose. Radiology. 2008;249(3):872–7.
Murakami T, Kim T, Kawata S, Kanematsu M, Federle MP, Hori M, et al. Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography. Invest Radiol. 2003;38(8):497–503.
Bae KT, Tran HQ, Heiken JP. Multiphasic injection method for uniform prolonged vascular enhancement at CT angiography: pharmacokinetic analysis and experimental porcine model. Radiology. 2000;216(3):872–80.
Utsunomiya D, Awai K, Sakamoto T, Nishiharu T, Urata J, Taniguchi A, et al. Cardiac 16-MDCT for anatomic and functional analysis: assessment of a biphasic contrast injection protocol. Am J Roentgenol. 2006;187(3):638–44.
Cameron JR, Skofronick JG, Grant RM. Physics of the body (second edition). Madison: Medical Physics Publishing; 1999. p. 181–2.
Hudson DM. Top shelf human anatomy and physiology. Portland: Walch Education Publishing; 2005. p. 134–5.
Bae KT. Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology. 2010;256(1):32–61.
Terasawa K, Hatcho A. Contrast enhancement technique in brain 3D-CTA studies: optimizing the amount of contrast medium according to scan time based on TDC. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2008;64(6):681–9 (in Japanese).
Yamaguchi I, Kidoya E, Suzuki M, Kimura H. Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography. Radiol Phys Technol. 2011;4(1):43–52.
Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology. 1998;207(3):657–62.
Awai K, Takada K, Onishi H, Hori S. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT. Radiology. 2002;224(3):757–63.
Fleischmann D. CT angiography: injection and acquisition technique. Radiol Clin North Am. 2010;48(2):237–47.
Kim T, Murakami T, Takahashi S, Tsuda K, Tomoda K, Narumi Y, et al. Effects of injection rates of contrast material on arterial phase hepatic CT. Am J Roentgenol. 1998;171(2):429–32.
Wang CL, Cohan RH, Ellis JH, Adusumilli S, Dunnick NR. Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69,657 intravenous injections. Radiology. 2007;243(1):80–7.
Aviram G, Cohen D, Steinvil A, Shmueli H, Keren G, Banai S, et al. Significance of reflux of contrast medium into the inferior vena cava on computerized tomographic pulmonary angiogram. Am J Cardiol. 2012;109(3):432–7.
Terasawa K, Hatcho A, Muroga K. Assessment of contrast enhancement using the variable contrast medium injection method in 3D-CTA of the head. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2005;61(1):126–34 (in Japanese).
Muroga K, Hatcho A, Terasawa K. Evaluation of the variable-speed injection method for three-dimensional CT angiography of the trunk. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2005;61(1):110–7 (in Japanese).
Yanaga Y, Awai K, Nakamura T, Namimoto T, Oda S, Funama Y, et al. Optimal contrast dose for depictin of the hypervascular hepatcellular carcinoma at dynamic CT using 64-MDCT. Am J Roentgenol. 2008;190(4):1003–9.
Conflict of interest
Our study is basic research involving a new method of contrast-enhanced CT examination and, therefore, does not require ethical approval. All authors have approved the content and the submission of the manuscript. The authors declare no particular conflicts of interest relevant to this manuscript. The manuscript has not been submitted to other publications. We have received no research grant funding for this study.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Terasawa, K., Maruyama, A. & Tsukimata, T. A new method with variable injection parameters in contrast-enhanced CT: a phantom study for evaluating an aortic peak enhancement. Radiol Phys Technol 8, 248–257 (2015). https://doi.org/10.1007/s12194-015-0314-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12194-015-0314-5